Skip to content
Home/Companies/Healthcare/Stallergenes
Stallergenes

Stallergenes

Healthcare·France·Exited 2010·Held 17yr
Entry
1993
Hold
17yr
Exit
2010

Who owns Stallergenes?

Stallergenes was owned by Wendel through Wendel SE (1995 vintage) from 1993 to 2010, exited via Trade Sale.

Buyer identity and MOIC available on Pro.

Hand-verified · updated 2026-07-13

Wendel
Investor
Wendel
Wendel SE · 1995 · Buyout

Key facts

HQFrance
SectorHealthcare
StatusAcquired
Websitewww.stallergenesgreer.com
Exit Type
Trade Sale
Buyer
MOIC
Exit Year
2010

More from Wendel SE

Other portfolio companies in the same fund.

Committed Advisors
Active
FinancialsFrance· 2026
Monroe Capital
Active
FinancialsUS· 2025
Globeducate
Globeducate
Active
ConsumerUK· 2024
IK Partners
IK Partners
Active
FinancialsFrance· 2023
Scalian
Scalian
Active
Business ServicesFrance· 2023
Acams
Active
Business ServicesUS· 2022

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Stallergenes

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Stallergenes?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Stallergenes.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue